This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Regeneron Pharmaceuticals Inc (REGN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 648.72M 535.61M 230.28M 483.61M
Receivables 1.02B 891.78M 693.12M 103.04M
Inventories 128.86M 70.35M 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 2.17B 1.80B 1.21B 652.88M
Property, Plant & Equipment, Gross 1.23B 748.60M 560.45M 526.09M
Accumulated Depreciation & Depletion 253.98M 221.62M 180.51M 158.14M
Property, Plant & Equipment, Net 974.31M 526.98M 379.94M 367.96M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 463.19M 395.22M 302.52M 302.75M
Total Non-Current Assets 1.70B 1.15B 874.48M 670.71M
Liabilities & Shareholder Equity
Total Assets 3.87B 2.95B 2.08B 1.32B
Accounts Payable 99.51M 61.94M 38.93M 27.74M
Short Term Debt 0.00 939.00K 1.37M 1.01M
Other Current Liabilities 96.41M 0.00 0.00 0.00
Total Current Liabilities 654.66M 298.84M 163.55M 148.27M
Long Term Debt 146.77M 320.32M 296.52M 275.02M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 217.13M 195.53M 215.60M 255.05M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 674.84M 700.10M 671.56M 689.58M
Total Liabilities 1.33B 998.94M 835.10M 837.85M
Preferred Stock Equity 0.00 0.00 2.00K 2.00K
Common Stock Equity 2.54B 1.95B 1.25B 485.73M
Common Par 104.00K 99.00K 95.00K 91.00K
Additional Paid In Capital 2.40B 2.05B 1.76B 1.75B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 255.38M -92.69M -517.05M -1.27B
Treasury Stock -169.53M 0.00 0.00 0.00
Other Equity Adjustments 52.25M -1.19M -1.17M -1.86M
Total Capitalization 2.69B 2.27B 1.54B 760.75M
Total Equity 2.54B 1.95B 1.25B 485.73M
Total Liabilities & Stock Equity 3.87B 2.95B 2.08B 1.32B
Total Common Shares Outstanding 102.43M 99.69M 97.29M 92.80M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 2.02M 0.00 0.00 0.00
Basic Weighted Shares Outstanding 100.61M 97.92M 94.68M 90.61M
Diluted Weighted Shares Outstanding 113.41M 111.29M 115.38M 90.61M
Number of Employees 2925 2340 1950 1704
Number of Part-Time Employees 0 0 0 0

REGN Regeneron Pharmaceuticals Inc

Chart of REGN

Analysts Ratings for REGN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 8 10 10
Moderate Buy 2 3 2 2
Hold 9 8 7 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 0

REGN Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs